| Identification | Back Directory | [Name]
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide | [CAS]
521284-19-5 | [Synonyms]
Mirabegron INT 1
Lactose Impurity 13
2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide
(R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide
(R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide
Mirabegron Impurity 8 (Mirabegron stage -I Impurity )
R-a-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide
(R) -N- (4-Nitrophenylethyl) -2-hydroxy-2-phenylacetamide
(2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide
R-alpha-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide
BenzeneacetaMide, -hydroxy-N-[2-(4-nitrophenyl)ethyl]-, (R)-
BenzeneacetaMide, a-hydroxy-N-[2-(4-nitrophenyl)ethyl]-, (aR)-
R-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol hydrochloride
(ALPHAR)-ALPHA-hydroxy-N-[2-(4-nitrophenyl)ethyl]phenylacetamide
(R) Alpha hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide
(R) -2- hydroxy -N- [2- (4- nitrophenyl) ethyl] -2-phenylacetamide
(Alphar) -α-hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide
High purity CAS 521284-19-5 (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide in stock | [EINECS(EC#)]
300-560-8 | [Molecular Formula]
C16H16N2O4 | [MDL Number]
MFCD22200231 | [MOL File]
521284-19-5.mol | [Molecular Weight]
300.31 |
| Chemical Properties | Back Directory | [Melting point ]
116-119°C | [Boiling point ]
584.8±50.0 °C(Predicted) | [density ]
1.294 | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
12.50±0.20(Predicted) | [color ]
Off-White to Pale Yellow |
| Hazard Information | Back Directory | [Uses]
(2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide is an intermediate used to prepare (aminothiazolyl)acetanilide derivatives via coupling reactions for treatment of diabetes. | [Uses]
(ALPHAR)-ALPHA-hydroxy-N-[2-(4-nitrophenyl)ethyl]phenylacetamide is an organic amide, which can be used as a pharmaceutical intermediate. |
|
|